Publication: Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms
| dc.contributor.author | Joshi M.S. | |
| dc.contributor.author | Wattanapitayakul S. | |
| dc.contributor.author | Schanbacher B.L. | |
| dc.contributor.author | Bauer J.A. | |
| dc.date.accessioned | 2021-04-05T03:34:58Z | |
| dc.date.available | 2021-04-05T03:34:58Z | |
| dc.date.issued | 2011 | |
| dc.date.issuedBE | 2554 | |
| dc.description.abstract | The functional relevance of NOS3 and ACE genetic variations to endothelial cell function is largely unstudied. Here we tested the functional relevance of the NOS3 (Glu298Asp) polymorphism and ACE (I/D) polymorphism in endothelial cells in vitro. Our hypothesis was that these genetic polymorphisms alter endothelial cell sensitivity to glucose and 3-nitrotyrosine (3NT). Genotyped HUVECs were incubated with glucose, free 3NT or a combination of these two toxicants. Significant differences in glucose-induced cell death and free 3NT-induced cell death were observed among the NOS3 genotypes. Combined glucose/3NT caused increased toxicity among the NOS3 genotypes. No differences were observed among the ACE genotypes in their responses to glucose/3NT. These data demonstrate that the NOS3 genotype may be an important predictor of, or be mechanistically involved in, endothelial vulnerability, whereas the ACE I/D genotype is apparently less important. Thus this NOS3 genetic variation may play a role in vulnerability to endothelium-dependent diabetic vascular complications. © SAGE Publications 2011. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Diabetes and Vascular Disease Research. Vol 8, No.4 (2011), p.276-283 | |
| dc.identifier.doi | 10.1177/1479164111416679 | |
| dc.identifier.issn | 14791641 | |
| dc.identifier.other | 2-s2.0-80053058309 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/7234 | |
| dc.rights.holder | มหาวิทยาลัยศรีนครินทรวิโรฒ | |
| dc.subject.other | 3 nitrotyrosine | |
| dc.subject.other | Dipeptidyl carboxypeptidase | |
| dc.subject.other | Endothelial nitric oxide synthase | |
| dc.subject.other | Glucose | |
| dc.subject.other | Article | |
| dc.subject.other | Cell death | |
| dc.subject.other | Cell viability | |
| dc.subject.other | Cellular stress response | |
| dc.subject.other | Genetic polymorphism | |
| dc.subject.other | Genetic variability | |
| dc.subject.other | Genotype | |
| dc.subject.other | Human | |
| dc.subject.other | Human cell | |
| dc.subject.other | Human cell culture | |
| dc.subject.other | Hyperglycemia | |
| dc.subject.other | In vitro study | |
| dc.subject.other | Umbilical vein endothelial cell | |
| dc.subject.other | Caveolin 1 | |
| dc.subject.other | Cell Death | |
| dc.subject.other | Cells, Cultured | |
| dc.subject.other | Diabetic Angiopathies | |
| dc.subject.other | Genotype | |
| dc.subject.other | Glucose | |
| dc.subject.other | Human Umbilical Vein Endothelial Cells | |
| dc.subject.other | Humans | |
| dc.subject.other | Hyperglycemia | |
| dc.subject.other | Nitric Oxide Synthase Type III | |
| dc.subject.other | Nitrites | |
| dc.subject.other | Peptidyl-Dipeptidase A | |
| dc.subject.other | Phenotype | |
| dc.subject.other | Phosphorylation | |
| dc.subject.other | Polymorphism, Genetic | |
| dc.subject.other | Proto-Oncogene Proteins c-akt | |
| dc.subject.other | Tyrosine | |
| dc.title | Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053058309&doi=10.1177%2f1479164111416679&partnerID=40&md5=ef314d3a53012d3c76722432c8a500e2 |
